Mainz Biomed N.V.
Robert Koch Strasse 50
Mainz 55129
Germany
49 6131 554 2860
https://mainzbiomed.com
版塊: Healthcare
行業: Diagnostics & Research
全職員工: 65
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Guido Baechler | CEO & Executive Director | 無 | 無 | 1965 |
| Mr. William J. Caragol | Chief Financial Officer | 無 | 無 | 1967 |
| Dr. Christopher Von Torne P.M.P., Ph.D. | Chief Operating Officer | 無 | 無 | 1972 |
| Dr. Frank Krieg-Schneider | Chief Technology Officer | 無 | 無 | 1962 |
| Dr. Moritz Eidens Ph.D. | Chief Science Officer & Executive Director | 無 | 無 | 1984 |
| Stefan Erlach | Head of Human Resources | 無 | 無 | 無 |
| Mr. Philipp Freese | Chief Business Officer | 無 | 無 | 1983 |
截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。
描述
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.
公司管治
截至 無 止，Mainz Biomed N.V. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
